Related Experiment Video

Updated: Oct 10, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

R Betarbet1, T B Sherer, G MacKenzie

  • 1Department of Neurology, Emory University, 1639 Pierce Drive, WMB 6000, Atlanta, Georgia 30322, USA.

Nature Neuroscience
|December 2, 2000
PubMed

Insights

Pesticide exposure, specifically rotenone, can trigger Parkinson's disease (PD) symptoms and brain changes. This study shows rotenone causes selective neuron loss and protein clumps seen in PD.

Area of Science:

  • Neuroscience
  • Toxicology
  • Environmental Health

Background:

  • The etiology of Parkinson's disease (PD) remains largely unknown.
  • Epidemiological data suggest a potential link between pesticide exposure and PD.
  • Biochemical evidence points to mitochondrial complex I dysfunction in PD.

Purpose of the Study:

  • To investigate the effects of chronic systemic exposure to the pesticide rotenone on the nigrostriatal dopaminergic system.
  • To determine if rotenone exposure can replicate the key features of Parkinson's disease.

Main Methods:

  • Administered rotenone, a lipophilic pesticide, systemically to rats for chronic exposure.
  • Assessed neurochemical, behavioral, and neuropathological changes, focusing on nigrostriatal dopaminergic neurons.
  • Examined neuronal inclusions for ubiquitin and alpha-synuclein.

Main Results:

  • Chronic rotenone exposure induced selective degeneration of nigrostriatal dopaminergic neurons.
  • Treated rats exhibited behavioral deficits, including hypokinesia and rigidity.
  • Nigral neurons developed fibrillar cytoplasmic inclusions containing ubiquitin and alpha-synuclein.

Conclusions:

  • Chronic systemic exposure to rotenone can recapitulate the hallmark features of Parkinson's disease.
  • This pesticide may serve as a valuable tool for studying PD pathogenesis.
  • Environmental toxins like rotenone are plausible contributors to Parkinson's disease development.

More Related Videos

Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment10:33

Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment

Published on: May 15, 2026

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...